Provider News
OncoLink Cancer Resource Home

 

 
OncoLink Cancer Resource Home

Provider News and Information  (update 2/1/2012)

OncoLink Cancer Resource Home
Types of Cancer Home
OncoLink Cancer Resource
Cancer Treatment Information Physician List
OncoLink Cancer Resource
Coping with Cancer MCC Staff
OncoLink Cancer Resource
Cancer Clinical Trials Matching Service Provider News
OncoLink Cancer Resource
Cancer Resources and News Women's News
OncoLink Cancer Resource
Ask the Cancer Experts Men's News
OncoLink Cancer Resource
OncoLink Cancer Library Treatment Protocols
OncoLink Cancer Resource
Cancer and Oncology Sponsors Cancer Control Protocols
OncoLink Cancer Resource
Giving to Oncolink's Cancer Resources Radiation Oncology
About Oncolink's Cancer Resources Upcoming Protocols
OncoLink
Giving to Oncolink's Cancer Resources Closed Protocols
Giving to Oncolink's Cancer Resources Related Links
   
 


 

 

MCC Administration

Benjamin Marchello, M.D.                 Principal Investigator bmarchello@hocnr.com

Grant Harrer, MD                               Co-Principal Investigator drharrer@benefis.net

James Burke, MD                               NCCTG Group Lead jburke@billingsclinic.org

James Hueftle, MD                             SWOG Group Lead jhueftle@prodigy.net

Thomas Warr, MD                               NSABP Group Lead thomas.warr@gfclinic.com

John Schallenkamp, MD                      RTOG Group Lead     jschallenkamp@billingsclinic.org

David Myers, MD                                Cancer Control Group Lead dmyers01@gmail.com


News and Information


     Cooperative Group Meetings

Alliance           June 28-30, 2012                                            SWOG             Apr. 11-14, 2012                                                         RTOG             Jan. 19-22, 2012                                               NSABP            Apr. 26-29, 2012                                                                                                                                                                       See Cooperative Group websites for registration                                     Travel on this page for MCC policy and reimbursement information

                 

Common Toxicity Criteria Tables

RECIST Quick Reference Guide

 

New Protocols Opened  (Updated 2/1/2012)

  

Travel  (updated 7/2011)

MCC Travel Policy                                     Travel Request Form                                  Travel Reimbursement Form

Investigational Agents                      PMB Agent Distribution Policy

 

                      New Protocols              

                              Cancer Control  

NCCTG N10C2  Protocol   Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes

SWOG S0927  Protocol   A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness in Women with Early Stage Breast Cancer, Phase III

                                           

           

                                   Prevention

NSABP P-5    Protocol   Fact Sheet    Statin Polyp Prevention Trial in Patients with Resected Colon Cancer

SWOG S0812  Protocol  A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of High Dose Vitamin D in Premenopausal Women at High-risk for Breast Cancer, Phase IIB

 

 
                                   Treatment

CTSU E2607 Protocol  Schema   (temporary closure 1/13/2012) A Phase II Trial of Dasatinib in KIT-Positive Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melanomas

SWOG S1108   Protocol   A Phase II Trial of the Aurora Kinase A Inhibitor MLN8237, in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

 

 

 

 

 

 

 

 

 

OncoLink Cancer Resource Home